Abstract

Abnormal IgA1 O-Glycosylation in a Multi-ethnic population of IgA Nephropathy Patients in KwaZulu Natal, South Africa.

Highlights

  • The pathogenesis of IgA Nephropathy (IgAN) is poorly understood globally and curative therapy currently does not exist

  • Novak et al reported that enhanced mesangial cell proliferation was caused by galactose-deficient IgA1-containing circulating immune complexes from the sera of IgAN patients than uncomplexed IgA1 or immune complexes from healthy control subjects (2005)

  • Studies in Caucasian, Asian and African American patients demonstrated elevated levels of galactose-deficient IgA1 in both IgAN patients and their first degree relatives in comparison to controls (Hastings et al, 2010; Lin et al, 2009; Gharavi et al, 2008), an additional requirement for the pathogenic mesangial deposition of IgA1 is the presence of autoantibodies specific for galactose-deficient IgA1

Read more

Summary

Non-specific and Non-Curative Treatment

1.8.4 The Pathogenesis of IgAN is Incompletely Understood 1.9 Study Aim and Hypothesis CHAPTER 2 - METHODS 2.1 Concise Study Design 2.2 Ethical and Study Approval 2.3 Participant Recruitment. 2.3.1 IgAN Patient Participants 2.3.2 Control Participants and Urinalysis 2.4 Participant Description 2.4.1 Control Population Description 2.4.2 Experimental Population Description 2.5 Whole Blood Extraction and Separation 2.5.1 Whole Blood Extraction 2.5.2 Whole Blood Separation. 2.5.2.1 Sample Encoding 2.5.2.2 Whole Blood Separation and Serum Storage 2.6 IgA1 O-Glycosylation Analysis 2.6.1 Experimental Design 2.6.2 Reagent Preparation and Storage

Methods
Conclusion
Definition of IgAN
Role and Structure of IgA
The Regulatory and Excretory Roles of the Kidney are affected in IgAN
Diagnosis and Clinical Manifestation of IgAN
Prognosis in IgAN
Galactose-Deficient IgA1 Selectively Deposit in the Renal Mesangium
Up-regulation of Macrophage Migration Inhibitory Factor and Renin
Increased Apoptosis Rate and Nitric Oxide Synthesis
Advantages of the Lectin Binding Approach to IgA1 OGlycosylation Analysis
Anti-galactose-deficient IgA1 Antibodies and IgA1 Glycoform Heterogeneity
The Pathogenesis of IgAN is Incompletely Understood
Study Aim and Hypothesis
Concise Study Design
Ethical and Study Approval
IgAN Patient Participants
Control Participants and Urinalysis
Control Population Description
Experimental Population Description
Whole Blood Extraction and Separation
Whole Blood Separation
Whole Blood Separation and Serum Storage
Experimental Design
Reagent Preparation and Storage
IgA1 O-Galactosylation in Pre-dialysis versus End-stage IgAN Patients
Incidence Data for Black and Indian IgAN Patients in KwaZulu Natal
Screening and Prognostic Potential of the Lectin Binding Assay for IgAN
Mechanisms Responsible for Abnormal IgA1 OGalactosylation
Background
That you include the statement
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.